Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Long-Term-Assets" stands at 4.78 Billion United States Dollars as of 09/30/2025, the highest value since 12/31/2017.
As of the end of Novartis AG's third quarter, the item "Other Long Term Assets" stands at 4.78 Billion USD. This represents an increase of 6.91 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.39 Billion United States Dollars compared to the value the year prior.
The 1 year change is 3.39 Billion United States Dollars.
The 3 year change is 1.59 Billion United States Dollars.
The 5 year change is 3.93 Billion United States Dollars.
The 10 year change is -19.99 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Long Term Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Long Term Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Long Term Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Long Term Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Long Term Assets | 280,205,508,085.11 |